Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
13.01.25
/
50%
€41.20
Target price
13.01.26
€137.24
Performance (%)
-50.00%
End price
14.01.26
€20.60
Summary
This prediction ended on 14.01.26 with a price of €20.60. The BUY prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc. performed very badly with a performance of -50.00%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -3.409% | -3.409% | -52.514% |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Piper Sandler from $135.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€35.20
17.03.25
17.03.25
€105.64
17.03.26
17.03.26
-46.59%
18.03.26
18.03.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€30.80
25.10.23
25.10.23
€122.98
25.10.24
25.10.24
61.04%
26.10.24
26.10.24